Changes in red blood cells membrane protein composition during hemodialysis procedure

Renal Failure

Volumn 30, Issue 10, 2008, Pages 971-975

  Costa, Elísio ^a,b,c   Rocha, Susana ^a,b   Rocha Pereira, Petronila ^d   Castro, Elisabeth ^a,b   Miranda, Vasco ^e   Faria, Maria Do Sameiro ^e   Loureiro, Alfredo ^f   Quintanilha, Alexandre ^a,b   Belo, Luís ^a,b   Santos Silva, Alice ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

^d UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^e FRESENIUS MEDICAL CARE PORTUGAL   (Portugal)

^f Uninefro Santo Tirso Sociedade Prestadora de Cuidados Medicos e Dialise SA   (Portugal)

Author keywords

Chronic kidney disease; Chronic renal failure; Erythrocyte membrane proteins; Hemodialysis; Resistance to rhEPO; Spectrin

Indexed keywords

CELL MEMBRANE PROTEIN; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROCYTE BAND 4.1 PROTEIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SPECTRIN;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ERYTHROCYTE COUNT; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REDUCTION; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TREATMENT RESPONSE;

EID: 57049083002     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802422036     Document Type: Article

References (16)

1. Reliene R, Marini M, Zanella A, Reinhart WH, Ribeiro ML, del Giudice EM, Perrotta S, Ionoscon A, Eber S, Lutz HU. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood. 2002;100:2208-2215.
2. Gallagher PG. Red cell membrane disorders. Hematology Am Soc Hematol Educ Program. 2005:13-18.
3. Rocha S, Rebelo I, Costa E, Catarino C, Belo L, Castro EMB, Cabeda JM, Barbot J, Quintanilha A, Santos-Silva A. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur J Hematol. 2005; 74:374-380.
4. Locatelli F, Conte F, Marcelli D. The impact of hematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy dialysis registry. Nephrol Dial Transplant. 1998;13: 1642-1644.
5. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs. 2005;29:67-72.
6. Stoya G, Klemm A, Baumann E, Vogelsang H, Ott U, Linss W, Stein G. Determination of autofluorescence of red blood cells (RbCs) in uremic patients as a marker of oxidative damage. Clin Nephrol. 2002;58:198-204.
7. Costa E, Rocha S, Rocha-Pereira P, Castro E, Miranda V, Sameiro-Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A. Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under hemodialysis and recombinant human erythropoietin therapy. Blood Purif. 2008;26:267-273.
8. Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt KU, Horl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S; European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19 (Suppl. 2): ii1-ii47.
9. Levin RD, Kwaan HC, Ivanivich P. Changes in platelet functions during hemodialysis. J Lab Clin Med. 1978;92: 779-786.
10. Craddock PR, Fehr J, Brigham KL, Kronemberg RS, Jacob HS. Complement and leukocyte mediated pulmonary dysfunction in hemodialysis. N Eng J Med. 1977;296:769-774.
11. Craddock PR, Hammerschmidt DE, White JG, Dalmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro: A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977;60: 260-264.
12. Dolegowska B, Kwiatkowska E, Wesolowska T, Bober J, Chlubek D, Ciechanowski K. Effect of hemodialysis on the content of fatty acids in monolayers of erythrocyte membranes in patients with chronic renal failure. Ren Fail. 2007;29:447-452.
13. Brimble KS, McFarlane A, Winegard N, Crowther M, Churchill DN. Effect of chronic kidney disease on red blood cell rheology. Clin Hemorheol Microcirculation. 2006;34: 411-420.
14. Dasselaar JJ, Hooge MNL, Pruim J, Nijnuis H, Wiersum A, Jong PE, Huisman RM, Franssen CFM. Relative blood volume changes underestimated total blood volume changes during hemodialysis. Clin J Am Soc Nephrol. 2007;2:669-674.
15. Yu AW, Nawab ZM, Barnes WE, Lai KN, Ing TS, Daugirdas JT. Splanchnic erythrocyte content decreases during hemodialysis: A new compensatory mechanism for hypovolemia. Kidney Int. 1997;51:1986-1990.
16. Costa E, Lima M, Alves JM, Rocha S, Rocha-Pereira P, Castro E, Miranda V, Sameiro-Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A. Inflammation, T-cell phenotype and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol. 2008;28:268-275.